• Iraklis Tsangaris, Nikolaos Antonakos, Massimo Fantoni, Gilles Kaplanski, Evdoxia Kyriazopoulou, Francisco Veas, and Mark Clemens.
• 2nd Department of Critical Care Medicine, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
• Shock. 2023 Mar 1; 59 (3S Suppl 1): 162016-20.

AbstractOptimal management of septic patients requires accurate assessment of both current severity status and prognosis. Since the 1990s, substantial advances have been made in the use of circulating biomarkers for such assessments. This summary of the session on "Biomarkers: can they really use guide our daily practice?" presented at the 2021 WEB-CONFERENCE OF THE EUROPEAN SHOCK SOCIETY, 6 November 2021. These biomarkers include ultrasensitive detection of bacteremia, circulating soluble urokina-type plasminogen activator receptor (suPAR), C-reactive protein (CRP) and ferritin and procalcitonin. In addition, the potential application of novel multiwavelength optical biosensor technology allows noninvasive monitoring of multiple metabolites that can be used to assess severity and prognosis in septic patients. The application these biomarkers and improved technologies provide the potential for improved personalized management of septic patients.Copyright © 2023 by the Shock Society.

6 keywords...

hide…